In this webinar, Bhavesh Patel and Shrinidhi Chakravarthy of CRA’s Life Sciences Consulting Practice explored how a customized approach could help rare disease (RD) companies identify and maintain RD patients unlocking the true potential of the product and optimizing performance. CRA presented an integrated approach on Market Sizing, Patient Finding, and Patient Tracking for successful RD asset commercialization, which applies at various stages from opportunity assessment and clinical development to commercialization and lifecycle management.
Roundtable: Transitioning Medical Affairs to strategically co-lead clinical development and commercialization efforts
In May 2023, CRA’s Life Sciences Practice held a roundtable discussion with Medical Affairs leaders in Lisbon on best practices in transitioning from a...